miR-301b-3p Regulates Breast Cancer Cell Proliferation, Migration, and Invasion by Targeting NR3C2

• Published in: Journal of oncology 2021, Vol.2021, p.8810517-9
• Main Authors: Fan, Yaohua, Li, Yan, Zhu, Yuzhang, Dai, Guiping, Wu, Dongjuan, Gao, Zhenzhen, Zhang, Lei, Xu, Danying
• Format: Article
• Language: English
• Subjects: Analysis; Binding sites; Bioinformatics; Breast cancer; Cancer; Cell adhesion & migration; Cell cycle; Cell growth; Datasets; Development and progression; Experiments; Medical equipment and supplies industry; Medical prognosis; Medical test kit industry; Metastasis; MicroRNA; Oncology, Experimental; Prognosis; Proteins; Software; Survival analysis
• ISSN: 1687-8450; 1687-8450
• DOI: 10.1155/2021/8810517

Objectives. Breast cancer is the most common malignant tumor among females, and miRNAs have been reported to play an important regulatory role in breast cancer progression. This study aimed to explore the function and underlying molecular mechanism of miR-301b-3p in breast cancer. Methods. Differential analysis and survival analysis were performed based on the data accessed from the TCGA-BRCA dataset for identification of the target miRNA. Bioinformatics analysis was conducted to predict the downstream target gene of the miRNA. Real-time quantitative PCR was carried out to detect the expression of miR-301b-3p and nuclear receptor subfamily 3 group C member 2 (NR3C2). Western blot was used to assess the protein expression of NR3C2. Cell counting kit-8 assay was performed to evaluate the proliferation of breast cancer cells. Transwell assay was conducted to determine the migratory and invasive abilities of breast cancer cells. Dual-luciferase reporter assay was employed to verify the targeting relationship between miR-301b-3p and NR3C2. Results. miR-301b-3p was elevated in breast cancer cell lines and promoted cell proliferation, migration, and invasion in terms of its biological function in breast cancer. NR3C2 was validated as a direct target of miR-301b-3p via bioinformatics analysis and dual-luciferase reporter assay, and NR3C2 was downregulated in breast cancer cell lines. The rescue experiment indicated that NR3C2 was involved in the mechanism by which miR-301b-3p regulated the malignant phenotype of breast cancer cells. Conclusion. The present study revealed for the first time that miR-301b-3p could foster breast cancer cell proliferation, migration, and invasion by targeting NR3C2, unveiling that miR-301b-3p is a novel carcinogen in breast cancer.